These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36041326)

  • 21. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryo-EM structure of the SARS-CoV-2 Omicron spike.
    Cerutti G; Guo Y; Liu L; Liu L; Zhang Z; Luo Y; Huang Y; Wang HH; Ho DD; Sheng Z; Shapiro L
    Cell Rep; 2022 Mar; 38(9):110428. PubMed ID: 35172173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the RBD mutations in the SARS-CoV-2 omicron: from spike opening to antibody escape and cell attachment.
    Hossen ML; Baral P; Sharma T; Gerstman B; Chapagain P
    Phys Chem Chem Phys; 2022 Apr; 24(16):9123-9129. PubMed ID: 35395667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
    Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS; Orekhov PS
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants.
    Westendorf K; Žentelis S; Wang L; Foster D; Vaillancourt P; Wiggin M; Lovett E; van der Lee R; Hendle J; Pustilnik A; Sauder JM; Kraft L; Hwang Y; Siegel RW; Chen J; Heinz BA; Higgs RE; Kallewaard NL; Jepson K; Goya R; Smith MA; Collins DW; Pellacani D; Xiang P; de Puyraimond V; Ricicova M; Devorkin L; Pritchard C; O'Neill A; Dalal K; Panwar P; Dhupar H; Garces FA; Cohen CA; Dye JM; Huie KE; Badger CV; Kobasa D; Audet J; Freitas JJ; Hassanali S; Hughes I; Munoz L; Palma HC; Ramamurthy B; Cross RW; Geisbert TW; Menacherry V; Lokugamage K; Borisevich V; Lanz I; Anderson L; Sipahimalani P; Corbett KS; Yang ES; Zhang Y; Shi W; Zhou T; Choe M; Misasi J; Kwong PD; Sullivan NJ; Graham BS; Fernandez TL; Hansen CL; Falconer E; Mascola JR; Jones BE; Barnhart BC
    bioRxiv; 2022 Mar; ():. PubMed ID: 33972947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome sequencing of SARS-CoV-2 omicron variants in Delhi reveals alterations in immunogenic regions in spike glycoprotein.
    Shikha S; Jogi MK; Jha R; Kumar RA; Sah T; Singh P; Sagar R; Kumar A; Marwal R; Ponnusamy K; Agarwal SM; Kumar RS; Arif N; Bharadwaj M; Singh S; Kumar P
    Front Immunol; 2023; 14():1209513. PubMed ID: 37849762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.
    Peter AS; Grüner E; Socher E; Fraedrich K; Richel E; Mueller-Schmucker S; Cordsmeier A; Ensser A; Sticht H; Überla K
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Class of Shark-Derived Single-Domain Antibodies can Broadly Neutralize SARS-Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape.
    Feng B; Chen Z; Sun J; Xu T; Wang Q; Yi H; Niu X; Zhu J; Fan M; Hou R; Shao Y; Huang S; Li C; Hu P; Zheng P; He P; Luo J; Yan Q; Xiong X; Liu J; Zhao J; Chen L
    Small Methods; 2022 Jul; 6(7):e2200387. PubMed ID: 35583124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation.
    Nguyen HL; Thai NQ; Nguyen PH; Li MS
    J Phys Chem B; 2022 Jun; 126(25):4669-4678. PubMed ID: 35723978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution.
    Wu CY; Yang YH; Lin YS; Shu LH; Cheng YC; Liu HT; Lin YY; Lee IY; Shih WT; Yang PR; Tsai YY; Chang GH; Hsu CM; Yeh RA; Wu YH; Wu YH; Shen RC; Tsai MS
    Heliyon; 2023 Jul; 9(7):e17701. PubMed ID: 37483781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization.
    Xiong D; Zhao X; Luo S; Cong Y; Zhang JZH; Duan L
    J Phys Chem Lett; 2022 Jul; 13(26):6064-6073. PubMed ID: 35758899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody.
    Yin W; Xu Y; Xu P; Cao X; Wu C; Gu C; He X; Wang X; Huang S; Yuan Q; Wu K; Hu W; Huang Z; Liu J; Wang Z; Jia F; Xia K; Liu P; Wang X; Song B; Zheng J; Jiang H; Cheng X; Jiang Y; Deng SJ; Xu HE
    Science; 2022 Mar; 375(6584):1048-1053. PubMed ID: 35133176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy.
    Zhao LP; Lybrand TP; Gilbert PB; Payne TH; Pyo CW; Geraghty DE; Jerome KR
    Sci Rep; 2022 Nov; 12(1):19089. PubMed ID: 36352021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron.
    Hu YF; Hu JC; Chu H; Yau T; Zhang BZ; Huang JD
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.